Semarion

Cambridge, United Kingdom · Founded 2018 · Privately Held (backing)

Developer of a drug discovery and cell microcarrier platform designed to revolutionize adherent cell screening. Semarion is based in Cambridge, United Kingdom and was founded in 2018. Its last reported valuation was $39.6 million in Mar 2025. It has raised $7 million.

Last reported valuation

$39.6M

Oct 2026

Priced at

—

Total raised

$7.0M

Last round

—

How much has Semarion raised?

$7.0Macross 0 recorded rounds

Free account

More of Semarion with a free account

·Watch Semarion: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Semarion investors

10 investors are on record for Semarion, including The FSE Group, Parkwalk Advisors, Cambridge Enterprise Ventures and Oxford Innovation Finance.

For fundraisers

Raising for a company like Semarion?

10 investors have backed Semarion.

See all 10 investors →

Frequently asked about Semarion

How much has Semarion raised?: Semarion has raised $7.0M in total across 0 recorded funding rounds.